Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at ...

The shot, made by Moderna, will be available for this year's upcoming flu season.

The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA ...

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.

The approval of the vaccine, called mFLUSIVA, which is manufactured by Moderna, follows a series of blows to mRNA research ...

Dr. Anthony Fauci texted health officials about a theoretical miscarriage risk from fever after the second mRNA dose in ...

This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab ...

Moderna received FDA approval for its new mRNA-based flu shot for older adults after months of regulatory questioning.

The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...

Vaccine makers can produce mRNA shots faster than those made with older technology, which could cut the risk of a mismatch ...